Two Sigma Investments’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.86M Buy
369,615
+97,080
+36% +$489K ﹤0.01% 1844
2025
Q1
$1.77M Buy
272,535
+26,659
+11% +$173K ﹤0.01% 1770
2024
Q4
$1.8M Sell
245,876
-30,148
-11% -$221K ﹤0.01% 1734
2024
Q3
$2.07M Sell
276,024
-80,521
-23% -$603K ﹤0.01% 1607
2024
Q2
$3.17M Buy
356,545
+291,033
+444% +$2.59M 0.01% 1186
2024
Q1
$664K Buy
65,512
+7,000
+12% +$70.9K ﹤0.01% 2136
2023
Q4
$589K Buy
58,512
+36,912
+171% +$371K ﹤0.01% 2291
2023
Q3
$202K Sell
21,600
-34,701
-62% -$325K ﹤0.01% 2563
2023
Q2
$1.38M Buy
56,301
+15,314
+37% +$376K ﹤0.01% 1685
2023
Q1
$954K Buy
40,987
+22,287
+119% +$519K ﹤0.01% 1819
2022
Q4
$473K Buy
+18,700
New +$473K ﹤0.01% 1991
2021
Q3
Sell
-26,300
Closed -$1.24M 3012
2021
Q2
$1.24M Buy
+26,300
New +$1.24M ﹤0.01% 1580